Fuchs SY - Search Results

1

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer.

Singh V, Singh A, Liu AJ, Fuchs SY, Sharma AK, Spiegelman VS. Singh V, et al. Among authors: fuchs sy. Cancers (Basel). 2024 Oct 16;16(20):3502. doi: 10.3390/cancers16203502. Cancers (Basel). 2024. PMID: 39456596 Free PMC article. Review.

2

Oncogenic beta-catenin signaling networks in colorectal cancer.

Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T. Fuchs SY, et al. Cell Cycle. 2005 Nov;4(11):1522-39. doi: 10.4161/cc.4.11.2129. Epub 2005 Dec 1. Cell Cycle. 2005. PMID: 16258275 Review.

3

Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

Tang W, Li Y, Yu D, Thomas-Tikhonenko A, Spiegelman VS, Fuchs SY. Tang W, et al. Among authors: fuchs sy. Cancer Res. 2005 Mar 1;65(5):1904-8. doi: 10.1158/0008-5472.CAN-04-2597. Cancer Res. 2005. PMID: 15753389

4

Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation.

Tang W, Pavlish OA, Spiegelman VS, Parkhitko AA, Fuchs SY. Tang W, et al. Among authors: fuchs sy. J Biol Chem. 2003 Dec 5;278(49):48942-9. doi: 10.1074/jbc.M307962200. Epub 2003 Sep 30. J Biol Chem. 2003. PMID: 14523018 Free article.

5

Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Li Y, Kumar KG, Tang W, Spiegelman VS, Fuchs SY. Li Y, et al. Among authors: fuchs sy. Mol Cell Biol. 2004 May;24(9):4038-48. doi: 10.1128/MCB.24.9.4038-4048.2004. Mol Cell Biol. 2004. PMID: 15082796 Free PMC article.

6

The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

Fuchs SY, Spiegelman VS, Kumar KG. Fuchs SY, et al. Oncogene. 2004 Mar 15;23(11):2028-36. doi: 10.1038/sj.onc.1207389. Oncogene. 2004. PMID: 15021890 Review.

7

Stabilization of prolactin receptor in breast cancer cells.

Li Y, Clevenger CV, Minkovsky N, Kumar KG, Raghunath PN, Tomaszewski JE, Spiegelman VS, Fuchs SY. Li Y, et al. Among authors: fuchs sy. Oncogene. 2006 Mar 23;25(13):1896-902. doi: 10.1038/sj.onc.1209214. Oncogene. 2006. PMID: 16278670

8

Inhibition of HOS expression and activities by Wnt pathway.

Spiegelman VS, Tang W, Katoh M, Slaga TJ, Fuchs SY. Spiegelman VS, et al. Among authors: fuchs sy. Oncogene. 2002 Jan 24;21(5):856-60. doi: 10.1038/sj.onc.1205132. Oncogene. 2002. PMID: 11850814

9

Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB.

Bhatia N, Herter JR, Slaga TJ, Fuchs SY, Spiegelman VS. Bhatia N, et al. Among authors: fuchs sy. Oncogene. 2002 Feb 28;21(10):1501-9. doi: 10.1038/sj.onc.1205311. Oncogene. 2002. PMID: 11896578

10

Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling.

Spiegelman VS, Tang W, Chan AM, Igarashi M, Aaronson SA, Sassoon DA, Katoh M, Slaga TJ, Fuchs SY. Spiegelman VS, et al. Among authors: fuchs sy. J Biol Chem. 2002 Sep 27;277(39):36624-30. doi: 10.1074/jbc.M204524200. Epub 2002 Jul 31. J Biol Chem. 2002. PMID: 12151397 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters